Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease artery disease
Phenotype C0011847|diabetes
Sentences 170
PubMedID- 22054019 Individuals with diabetes develop cardiomyopathy independent of coronary artery disease, hypertension or atherosclerosis [1-3].
PubMedID- 23408783 Combination of peroxisome proliferator-activated receptor alpha/gamma agonists may benefit type 2 diabetes patients with coronary artery disease through inhibition of inflammatory cytokine secretion.
PubMedID- 23609464 Serum s100a12 levels are correlated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
PubMedID- 23316284 Across all hf groups, plasma gal-3 did not correlate with age, sex, diabetes, history of coronary artery disease, hypertension, smoking history, systolic blood pressure, diastolic blood pressure, or body mass index.
PubMedID- 24621989 Risk factors for peripheral artery disease among patients with diabetes in saudi arabia.
PubMedID- 24070055 In our study population, the variables associated with increased mortality were age, chronic pulmonary disease, congestive heart failure, prior cerebrovascular event, diabetes, family history of coronary artery disease, pre- and post-operative renal failure requiring dialysis, intraoperative use of cardiopulmonary bypass (cpb), elevated preoperative neutrophil, nlr, serum creatinine, serum glucose, postoperative septicemia, and new onset atrial fibrillation (table 3).
PubMedID- 25898145 Exclusion criteria included congestive heart failure, peripheral artery disease with claudication, diabetes not under control via medication or diet, shortness of breath without exertion, unstable angina, resting heart rate outside the range of 40 to 100 beats per minute, resting blood pressure outside the range of 90/60 to 170/90 mm hg, inability to communicate with the investigators, pain in lower limbs or spine, total knee replacement, cerebellar involvement, and neglect (star cancellation test).
PubMedID- 25894234 Insulin and c-peptide levels were not significantly changed in the diseases groups as compared to control subjects, except diabetes with coronary artery diseases groups.
PubMedID- 23316958 On the contrary, the association between intraday glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes has been studied by su et al.
PubMedID- 23272439 Conclusion: presence of diabetes mellitus is associated with diffuse coronary artery disease and significant carotid artery disease in patients undergoing coronary artery bypass grafting.
PubMedID- 21063711 2segmental coronary artery disease in patients with and without diabetes mellitus.
PubMedID- 23421972 Surgical revascularization (cabg) remains the best evidence based treatment for atherosclerotic multivessel coronary artery disease in patients with diabetes, despite improvements in percutaneous interventional techniques (pci) and medical therapy.
PubMedID- 24396702 Letter: a1c variability can predict coronary artery disease in patients with type 2 diabetes with mean a1c level greater than 7 (endocrinol metab 2013;28:125-32, eun ju lee et al.).
PubMedID- 25938439 Ir plays a key role in the pathogenesis of atherosclerosis, from the initiation and progression of disease to the formation of clinically significant plaques and coronary artery disease, even in patients without diabetes mellitus [9–11].
PubMedID- 24063840 Comparison of zotarolimus-eluting stent versus sirolimus-eluting stent for de novo coronary artery disease in patients with diabetes mellitus from the essence-diabetes ii trial.
PubMedID- 24888196 [prevalence and risk factors of extra-coronary artery disease in patients with diabetes which confirmed atherosclerosis of coronary arteries].
PubMedID- 26052512 diabetes is associated with coronary artery disease and an increased risk of heart failure, and pdi function is impaired in mouse models of diabetes.
PubMedID- 26268997 Alterations in lipid transfers to hdl associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
PubMedID- 22912424 The current study has extended the previous clinical observations showing that 1) ages were detected within an area of atherosclerosis in humans (19,20) and 2) serum level of ages is positively associated with inflammatory and thrombogenic biomarkers, endothelial dysfunction, and the presence of coronary artery disease in patients with diabetes or nondiabetic subjects (21–24).
PubMedID- 24396666 A1c variability can predict coronary artery disease in patients with type 2 diabetes with mean a1c levels greater than 7.
PubMedID- 21630285 The most common single etiology was valvular heart disease, and the most common triple etiology was hypertension and diabetes mellitus complicated by coronary artery disease.
PubMedID- 22493727 In other study, glp-1 infusion significantly increased relative changes in brachial artery diameter from baseline flow mediated dilatation (%) (3.1 ± 0.6 vs. 6.6 ± 1.0%, p < 0.05) in type 2 diabetes patients with coronary artery disease [29], just as glp-1 increased intracellular camp (from 5.7 ± 0.5 to 13.1 ± 0.12 pmol/mg protein) in rat cardiac myocytes [31].
PubMedID- 24666618 Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study).
PubMedID- 26413550 They reported that urinary albumin excretion rate was independently correlated with coronary artery disease in patients with type 2 diabetes mellitus.
PubMedID- 22328892 Several other studies comparing cabg and des-pci in diabetic patients are underway, including freedom (comparison of two treatments for multivessel coronary artery disease in individuals with diabetes) [http://www.clinicaltrials.gov.
PubMedID- 21525445 Although the mortality from coronary artery disease (cad) in patients without diabetes has declined over the past 20 years, the mortality in men with type 2 diabetes has not changed significantly.
PubMedID- 26247098 Risk of developing coronary artery disease in patients with type 2 diabetes receiving traditional chinese medicine therapy.
PubMedID- 25018979 Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
PubMedID- 24376641 [8], [11] other groups have confirmed the association between skin ages and coronary artery disease in patients with type 1 diabetes, using a different setup, referred to as skin intrinsic fluorescence.
PubMedID- 24282409 This review examines potential biological markers, ykl-40, alpha-hydroxybutyrate, soluble cd36, leptin, resistin, interleukin-18, retinol binding protein-4, and chemerin, as they may play significant roles in insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease.
PubMedID- 21349201 Receiver-operating characteristic (roc) curve for mage and hemoglobin a1c (hba1c) in predicting coronary artery disease (cad) in patients with type 2 diabetes (t2dm).
PubMedID- 20225090 Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus.
PubMedID- 24879842 Objective: to study the ability of lipid variables to predict incident coronary artery disease (cad) events in patients with type 1 diabetes at different stages of nephropathy.
PubMedID- 22048611 The association between extracoronary calcification and coronary artery disease in patients with type 2 diabetes mellitus.
PubMedID- 24089535 Multivessel coronary artery disease in patients with diabetes remains a classic indication for coronary artery bypass grafting (cabg).
PubMedID- 21108053 The most frequent mutation of the ampd1 gene in the polish population is the c34t substitution, associated with reduced prevalence of diabetes and obesity in patients with coronary artery disease (cad) or heart failure (hf).
PubMedID- 20334678 A previous study showed an association between c161→t polymorphism in the pparγ gene and a reduced risk of coronary artery disease in patients with and without diabetes in an australian caucasian cohort [19].
PubMedID- 25561963 In another study by the same authors, involving around 3000 patients with type 2 diabetes, the prevalence of coronary artery disease was independently higher among patients with nafld than among those without this disease.20 similar findings were also reported by another study on type 1 diabetes.31 in type 2 diabetic patients with well-controlled metabolic status, even mild elevation in liver enzymes was proved to be independently related to decreased insulin sensitivity and impaired brachial artery flow-mediated vasodilation.32 in children, nafld in overweight individuals has been proven to be associated with multiple cardiovascular risk factors, including higher serum levels of fasting glucose, insulin, total cholesterol, low-density lipoprotein cholesterol, and triglycerides as well as higher systolic and diastolic blood pressure and lower high-density lipoprotein cholesterol, than overweight and obese children without nafld (controls).33 multivariable analysis in the same study revealed that the children with the metabolic syndrome had 5.0 (95%ci: 2.6-9.7) times the odds of having nafld as the controls.
PubMedID- 24400648 Diad (cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes) study [14] was a randomised trial that evaluated the impact of ischaemia screening in the prevention of cardiovascular events.
PubMedID- 24273550 Decreased mirna-126 was also found in atherosclerotic coronary artery disease (cad) and in patients with type 2 diabetes mellitus and may reflect the condition of vascular endothelial cells in heart failure patients (fukushima et al., 2011).
PubMedID- 24029567 The relation between systolic body mass index (bmi), hemoglobin (hb), serum uric acid (ua), total cholesterol(tc), triglyceride (tg), high density lipoprotein cholesterol (hdl-c), low density lipoprotein cholesterol (ldl-c), smoking history, essential hypertension, type 2 diabetes mellitus, familial history of early coronary artery disease with acute myocardial infarction and severity of coronary artery disease are observed.and observe the characteristics of hdl-c in the obesity group and the smoking group in young men based on body mass index and smoking history.
PubMedID- 24240785 Relationship between coronary artery disease and retinopathy in patients with type 2 diabetes mellitus.
PubMedID- 25236509 (comparison of two treatments for multivessel coronary artery disease in individuals with diabetes [freedom]; nct00086450).
PubMedID- 26521236 Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10 years of duration: a case control study.
PubMedID- 22716997 Although the use of des for treatment of coronary artery disease in patients with diabetes has increased, limited data exists on comparing the vascular responses of different des in relevant preclinical models of diabetes.
PubMedID- 20223369 Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
PubMedID- 24169284 [effects of allitridi capsules on endothelial function and clinical prognosis after percutaneous coronary intervention in coronary artery disease patients with diabetes mellitus].
PubMedID- 20591621 Methods: individuals aged < or = 65 years not taking statins and without diabetes mellitus or histories of coronary artery disease underwent cimt and plaque examination for primary prevention.
PubMedID- 24804267 Coronary artery disease resulting from diabetes is responsible for 75% of diabetes related deaths [2].
PubMedID- 22553938 Su et al [26] studied glycaemic variability determined by a continuous 72-hours glucose monitoring system and the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.

Page: 1 2 3 4